GENE EDITING
Optimise Your Gene Editing Projects with Enzymatic DNA Technology
Streamline your gene editing workflow with Touchlight’s proprietary enzymatic DNA technologies: dbDNA™, a covalently closed linear DNA vector and mbDNA™, a single–stranded circular DNA template engineered for seamless integration and exceptional performance. Optimised for homology-directed repair (HDR), dbDNA and mbDNA bring high-purity inputs, faster workflows, and clear results.
OVERVIEW
Accelerating gene editing with high-purity, scalable DNA solutions
70
Achieving over 70% knock-in efficiency
20
Compatible with large (>20kb) constructs
1
gene editing candidate in clinic
The Benefits of Gene Editing in Your Workflow
Our advanced cell-free DNA platforms eliminate biological limitations with no bacterial sequences or host cell contaminants, delivering you reliable gene editing reagents with high stability, purity, and efficiency.
Optimised templates for homology-directed repair.
High-purity DNA eliminates bacterial sequences.
Streamlined production for rapid research timelines.
Scalable synthesis for large-scale applications.
GMP-compliant material for clinical development.
Supporting diverse genome modification strategies.
Off-the-shelf catalogue products
Get started with our dbDNA™ off-the-shelf constructs:
NVGT
Lentivirus
AAV
Gene Editing
Touchlight vs competitors
Our technology offers enhanced precision and scalability on your drug development projects, while eliminating biological contamination while delivering superior purity and regulatory-ready DNA.
RESOURCES
Learn more about dbDNA™ and mbDNA™ and their role in advancing gene editing
Explore our latest research and insights into enzymatic DNA production innovation. Discover how it enhances genome modification, accelerating the processes in developing next-generation therapies.
